A prostate cancer risk calculator (PCRC-MRI): Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men
Adam Kinnaird(University of Alberta), Leonard S. Marks(Urological Research Foundation), Merdie Delfin(University of California, Los Angeles), Ryan Chuang(University of California San Diego), Lorna Kwan(University of California, Los Angeles), Jim C. Hu(Presbyterian Hospital), Daniel Margolis(Southern Methodist University), Danielle Barsa(University of California, Los Angeles), Wayne Brisbane(University of California, Los Angeles), Alan Priester(University of California, Los Angeles), Ely Felker(University of California, Los Angeles), Anthony Sisk(University of California, Los Angeles)
Cited by 10
Related Papers
Rewiring of Genetic Networks in Response to DNA Damage
|Science|2010|468
An overview of kidney stone imaging techniques
|Nature Reviews Urology|2016|389
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients
|Science Translational Medicine|2017|311
Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging
|Cancer Research|2014|264
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
|European Urology|2022|169